VTGN - VistaGen Therapeutics GAAP EPS of -$0.10 misses by $0.02 revenue of $0.31M beats by $0.07M August, 11 2022 04:30 PM VistaGen Therapeutics Inc. VistaGen Therapeutics press release ( NASDAQ: VTGN ): Q1 GAAP EPS of -$0.10 misses by $0.02 . Revenue of $0.31M (-11.4% Y/Y) beats by $0.07M . Shares -10% . For further details see: VistaGen Therapeutics GAAP EPS of -$0.10 misses by $0.02, revenue of $0.31M beats by $0.07M